The Nuclear Regulatory Commission held an virtual event and teleconference on SHINE Medical Technologies’ plans to license and operate a medical isotope production facility in Janesville, Wisconsin. The  online public meeting was b held on July 27 from 7:00 p.m. to 9 p.m. (EDT). The NRC is also seeking the public’s views regarding the agency’s draft supplemental environmental impact statement for SHINE’s application for a license to operate the facility, particularly regarding the conclusion that the environmental impacts are not great enough to prevent the NRC from considering issuance of the license.

To read more please visit:

NRC to hold webinar, collect comments on SHINE’s Mo-99 license

Source: ANS